Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib (Q46934958)
Jump to navigation
Jump to search
scientific article published in February 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib |
scientific article published in February 2006 |
Statements
1 reference
Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib (English)
1 reference
1 reference
William Pao
1 reference
Marc Ladanyi
1 reference
Gregory J Riely
1 reference
Maureen F Zakowski
1 reference
Naiyer Rizvi
1 reference
Duykhanh Pham
1 reference
Allan R Li
1 reference
Ennapadam S Venkatraman
1 reference
Vincent A Miller
1 reference
1 February 2006
1 reference
1 reference
12
1 reference
839-844
1 reference
3 Pt 1
1 reference
Identifiers
1 reference
1 reference